Drug Company Warned To Stop Marketing Budesonide Nasal Spray To Treat COVID-19

Mealey's (October 9, 2020, 3:50 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on Sept. 22 warned Nephron Pharmaceuticals Corp. to stop unapproved advertising that budesonide nasal asthma spray treats respiratory symptoms of COVID-19 infections....
To view the full article, register now.